Compare JFrog Ltd. Ordinary Shares (FROG) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JFrog Ltd. Ordinary Shares vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? JFrog Ltd. Ordinary Shares trades at $100.5 (market cap $11.99B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.43 (market cap $6.04B). The key difference: JFrog Ltd. Ordinary Shares is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 1,116,446). Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FROG | IOVA | |
|---|---|---|
Market Cap | $11.99B | $6.04B |
Volume | 1,116,446 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $104.03 | $14.82 |
52-Week Low | $34.75 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.18B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JFrog Ltd. Ordinary Shares
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
